Albers J W, Garabrant D H, Schweitzer S J, Garrison R P, Richardson R J, Berent S
Department of Neurology, University of Michigan, USA.
Occup Environ Med. 2004 Mar;61(3):201-11. doi: 10.1136/oem.2003.008847.
To determine whether chronic occupational exposure to chlorpyrifos at levels associated with various aspects of manufacturing produced a clinically evident or subclinical peripheral neuropathy.
Clinical and quantitative nerve conduction study (NCS) examinations were performed on two occasions on chlorpyrifos manufacturing workers who had measurable chlorpyrifos exposure and a referent group. Baseline evaluations were performed on 53 of 66 eligible chlorpyrifos subjects and on 60 of 74 eligible referent subjects; one-year evaluations were completed on 111 of the 113 subjects evaluated at baseline.
Chlorpyrifos and referent groups differed significantly in measures of 3,5,6 trichloro-2-pyridinol excretion and plasma butyrylcholinesterase (BuChE) activity, indicating substantially higher exposures among chlorpyrifos subjects. Few subjects had clinically important neurological symptoms or signs. NCS results were comparable to control values, and there were no significant group differences in NCS results at baseline, one year, or change over one year. No chlorpyrifos subject fulfilled conventional criteria for confirmed peripheral neuropathy at baseline or one-year examinations. The odds ratios for developing any diagnosable level of peripheral neuropathy among the chlorpyrifos subjects was not increased at baseline or at one year compared to referents at baseline. Mixed regression models used to evaluate subclinical group-by-time interactions showed numerous significant NCS differences attributable to near-nerve temperature differences among all subjects between the baseline and one-year examinations, but only a few disparate effects related to group.
Chronic chlorpyrifos exposure during the manufacturing process sufficient to produce biological effects on BuChE activity was not associated with clinically evident or subclinical peripheral neuropathy at baseline or with measurable deterioration among chlorpyrifos subjects compared to referents after one year of additional exposure.
确定在与生产各环节相关的水平下长期职业性接触毒死蜱是否会导致临床明显或亚临床周围神经病变。
对有可测量的毒死蜱接触史的毒死蜱生产工人及一个参照组进行了两次临床和定量神经传导研究(NCS)检查。对66名符合条件的毒死蜱接触者中的53名以及74名符合条件的参照对象中的60名进行了基线评估;在基线评估的113名受试者中,有111名完成了一年后的评估。
毒死蜱组和参照组在3,5,6 - 三氯 - 2 - 吡啶醇排泄量和血浆丁酰胆碱酯酶(BuChE)活性测量值上有显著差异,表明毒死蜱接触者的接触水平明显更高。很少有受试者有具有临床意义的神经症状或体征。NCS结果与对照值相当,在基线、一年时或一年间的变化方面,两组NCS结果无显著差异。在基线或一年检查时,没有毒死蜱接触者符合确诊周围神经病变的传统标准。与基线时的参照对象相比,毒死蜱接触者在基线或一年时出现任何可诊断水平周围神经病变的比值比并未增加。用于评估亚临床组间时间交互作用的混合回归模型显示,在基线和一年检查之间,所有受试者中许多显著的NCS差异可归因于近神经温度差异,但与组相关的差异效应很少。
在生产过程中慢性接触毒死蜱足以对BuChE活性产生生物学效应,但在基线时与临床明显或亚临床周围神经病变无关,与参照组相比,在额外接触一年后,毒死蜱接触者也没有可测量的病情恶化。